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Survival analysis of dialysis patients in Okinawa, Japan (1971—1990).
We analyzed longitudinal data obtained from the initiation of chronic
dialysis in Okinawa, Japan. A total of 1,982 patients (824 females and
1,158 males) were registered in the Okinawa Dialysis Study (OKIDS) up
to the end of 1990. The number of patients dying, undergoing renal
transplantation, or being transferred was 605 (30.5%), 75 (3.8%), and 23
(1.2%), respectively. The mean acceptance rate per million population
increased from 19.7 in 1971 to 1975 to 157.4 in 1986 to 1990. The
percentage of diabetic patients and the annual gross mortality rate were,
respectively 0% and 0.52 (1971 to 1975), 7.3% and 0.12 (1976 to 1980),
14.4% and 0.06 (1981 to 1985), and 24.6% and 0.07 (1986 to 1990). Cox
proportional hazard analysis was used to determine the relative risk
(RR) for sex, primary renal disease, age at entry, and the year of
starting dialysis. The RR for males was 1.09 (1.00 for females) and the
95% confidence interval (CI) was 0.93 to 1.28. The RR for diabetics was
1.88 (95% CI; 1.55 to 2.28) when that for nondiabetics was set at 1.00.
The RR (95% Cl) for starting dialysis in 1976 to 1980, 1981 to 1985, and
1986 to 1990 was 0.65 (0.59 to 0.72), 0.43 (0.35 to 0.52), and 0.28 (0.20
to 0.38), respectively, when the RR in 1971 to 1975 was taken as 1.00.
During the last two decades, the survival of chronic dialysis patients in
Okinawa has continued to improve despite the large increase in
acceptance rate, the older age of the new patients, and the increase in
diabetic patients. Better dialysis techniques and patient care may have
contributed to these results.
It has been shown that the mortality of chronic dialysis
patients is higher in the United States than in Europe and Japan,
although the reason for this is not clear [1, 2]. Eggers has argued
that the mortality of dialysis patients corrected for age and the
incidence of diabetes has remained constant [3]. The results of
chronic dialysis in Japan have been reported recently [4], but
not those of an independent local registry as have been pub-
lished from the USA [5—7].
Chronic maintenance hemodialysis began to spread rapidly to
all areas of Japan after 1968, but its introduction to Okinawa
was delayed by three years [4]. There are several reasons for
conducting an epidemiological study of dialysis patients in
Okinawa [8]; it is situated in the southernmost part of Japan and
is known as the district whose inhabitants have the longest
lifespan in this country [9]. Okinawa is made up of a number of
subtropical islands, and the population is stable at around 1.2
million. More than 95% of the Okinawan patients with end-
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stage renal disease remained on chronic dialysis therapy. A
review of the medical records and follow-up data were possible
through the collaboration of 27 dialysis units in the entire
Okinawa area.
The objectives of the present study were to describe the
characteristics of patients on chronic dialysis therapy over the
last two decades in Okinawa and to provide a longitudinal
analysis of survival using the Cox proportional hazard analysis.
Methods
Data for the Okinawa Dialysis Study (OKIDS) were obtained
through the collaboration of all the physicians in charge of
dialysis units in Okinawa. The medical records of all dialysis
patients were reviewed and further information was also ob-
tained from paramedical staff, the patients, and their families, if
this was necessary. Maintenance hemodialysis was initiated
from 1971 in Okinawa. Before this, uremic patients were
occasionally treated by intermittent peritoneal dialysis. Cur-
rently, there are 27 dialysis units and six of them are freestand-
ing.
The dialysis regimen initially appeared to be prescribed
intuitively. A cross-sectional survey on dialysis regimens was
done in January, 1991 in 1,243 patients and showed the follow-
ing. The weekly frequency of dialysis was once in 11 patients
(0.9%), twice in 191 patients (15.4%), and three times in 1,041
patients (83.7%). The duration of dialysis (hours per session)
was 3.0 to 3.5 hours in 65 patients (5.2%), 3.5 to 4.0 hours in 708
patients (57.0%), 4.0 to 5.0 in 125 patients (10.0%), and 5.0 in
345 patients (27.8%). The area of the dialyzer membrane used
(m2) was <1.0 in 60 patients (4.8%), 1.0 to 1.4 in 434 patients
(34.9%), 1.5 to 1.99 in 534 patients (43.0%), and 2.0 in 215
patients (17.3%). As a historical review, the coil type and plate
type dialyzers were replaced during the middle of the 1980's and
hollow fiber dialyzers are mainly used at present. Acetate
dialysate was gradually replaced in the mid-1980s and bicarbon-
ate dialysate is now mainly used. High sodium (>145 mEqlliter)
dialysate has never been used regularly. The other dialysis
techniques used were similar to those in other parts of Japan, as
noted previously [4].
The dialysis method used at one month after the onset of
end-stage renal disease (ESRD) was defined as the treatment
method used for each patient to avoid including patients in
whom a diagnosis of ESRD was incorrect [6].
The annual acceptance rate (AR) was calculated as the
number of new patients per million population who began
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Table 1. Chronic dialysis therapy in Okinawa (1971—1990)
Year
New pts
(DM) Death Transplant Transfer
Mean age of
new pts (DM) G.M.R.
1971 4 (0) 0 0 0 23.5 0.000
1972 11(0) 9 0 0 35.5 1.800
1973 24 (0) 7 0 0 36.4 0.483
1974 20 (0) 7 0 0 32.7 0.237
1975 39 (0) 12 0 0 34.5 0.242
1976 37(1) 18 2 0 33.9(31.0) 0.254
1977 47 (3) 8 0 0 38.6 (58.3) 0.081
1978 78 (5) 16 3 0 39,4 (47.8) 0.109
1979 83 (7) 13 1 1 42.6 (55.7) 0.062
1980 85 (9) 20 0 2 42.5 (59.0) 0.072
1981 86 (7) 22 2 0 43.3 (55.3) 0.065
1982 116 (16) 16 3 1 47.4 (58.2) 0.038
1983 129 (25) 29 2 1 47.7 (56.0) 0.057
1984 132 (18) 29 1 1 49.7 (54.1) 0.048
1985 138 (29) 53 5 0 49.6 (58.2) 0.076
1986 141 (26) 53 3 1 50.1 (58.0) 0.068
1987 169 (41) 54 11 3 53.4 (59.5) 0.063
1988 209 (48) 71 15 6 50.3 (59.7) 0.072
1989 197 (61) 80 13 6 54.6 (61.0) 0.072
1990 237 (78) 88 14 1 56.9 (62.7) 0.073
Total 1,982 (374) 605 75 23
The number of new patients, mean age at the start of dialysis, and
gross mortality rate (G.M.R.) are shown. Abbreviations are: DM,
diabetes mellitus; Pts, patients.
chronic dialysis each year. The population base for calculating
the rate was taken from the National Census and the annual
official report of the prefectural government [9]. It increased
slightly from 0.94 million in 1971 to 1.22 million in 1990. The
annual gross mortality rate (GMR) was calculated as the num-
ber of deaths divided by half the number of alive on January 1
plus half the number alive on December 31 of each year [7]. The
prevalence rate (PR) was calculated as the number of patients
on dialysis at December 31 per million population. Causes of
death were reevaluated and were grouped into six categories
[71.
A base analysis was performed to evaluate the relationship
between survival and patient characteristics such as age, sex,
primary renal disease, and year of starting dialysis using the
Statistical Analysis System package [10, 11]. The survival
distribution function, S(t), was used to describe the lifetime of
the dialysis population. The hazard function, h(t), which is the
ratio of probability of death at time t, was defined as:
dS(t)
h(t) =
— —j-—/S(t) [12].
Cox proportional hazard analysis was performed to determine
the relative risk (hazard ratio) of each clinical parameter with
respect to survival. Survival curves were drawn using the
Kaplan-Meier method. All dialysis patients were followed up to
death or to March 31, 1991. Patients were categorized into two
major groups consisting of those with diabetes mellitus and
nondiabetic patients. Nondiabetic patients with diseases such
as chronic glomerulonephritis and nephrosclerosis were consid-
ered together, since the criteria for the differential diagnosis of
these disease are neither simple nor standardized [13, 14]. The
number of patients with diabetes, lupus nephritis, and polycys-
Table 2. Clinical presence of predialysis comorbid conditions
Predialysis comorbid 1971—1980
condition N = 428
1981—1990
N = 1554
Total
N = 1982
ASHD 6 39 45 (2.3%)
COPD 6 24 30 (1.5%)
PVD 2 11 13 (0.7%)
MAL 1 48 49 (2.5%)
CVD 5 62 67 (3.4%)
Misc 4 57 61(3.1%)
Total 24 (5.6%) 241 (15.5%) 265 (13.4%)
Number of comorbid condition
None 406 (94.8%) 1335 (85.9%) 1741 (87.8%)
One 20 (4.7%) 197 (12.7%) 217 (11.0%)
Two 2 (0.5%) 22 (1.4%) 24 (1.2%)
Abbreviations are: ASHD, atherosclerotic heart disease; COPD,
chronic obstructive pulmonary disease; PVD, peripheral vascular dis-
ease; MAL, malignancy; CVD, cerebrovascular disease; Misc, miscel-
laneous.
tic kidney disease as the cause of ESRD was 374 (18.9%), 39
(2.0%), and 38 (1.9%), respectively. Age at entry was grouped
as 0 to 34 years, 35 to 44 years, 45 to 54 years, 55 to 64 years,
and 65 years. To evaluate the effect of general socioeconomic
progress on the characteristics studied, patient demographics
were tabulated into the following five-year periods: 1971 to
1975, 1976 to 1980, 1981 to 1985, and 1986 to 1990.
Table I summarizes the main features of chronic dialysis
therapy in Okinawa from 1971 to 1990. A total of 1,982 patients
(824 females and 1,158 males) had been introduced to chronic
dialysis therapy by the end of 1990. Deaths, renal transplanta-
tion, and transfer to other parts of Japan accounted for 605
(30.5%), 75 (3.8%), and 23 (1.2%) patients, respectively. Fifteen
of the 75 transplant patients re-started dialysis when their grafts
failed and are currently alive on dialysis, while five patients died
after renal transplantation. Patients transferred to other parts of
Japan were regarded as withdrawing alive from dialysis treat-
ment. A few patients (3.3%) were treated at least once by
intermittent peritoneal or CAPD during the observation period.
Thus, about 93% of the patients were maintained solely by
chronic hemodialysis. Diabetic patients were first enrolled in
1976. In 1990, more than 30% of the new patients were diabetic
(Table 1). The mean age of the new patients increased from 23.5
(1971) to 56.9 years (1990).
The presence of predialysis comorbid conditions was con-
firmed by review of the medical charts and these diseases were
grouped into six categories: atherosclerotic heart disease
(ASHD), cerebrovascular disease (CVD), peripheral vascular
disease (PVD), chronic obstructive pulmonary disease (COPD),
malignancies (MAL), and miscellaneous (Misc). The frequency
of each comorbid condition is summarized in Table 2. Cerebro-
vascular disease (3.4%) was the most prevalent condition in our
registry. If malignancy was diagnosed within one year of
starting dialysis, it was defined as a predialysis comorbid
condition. Two hundred and seventeen (11.0%) patients had
one comorbid condition and 24(1.2%) had two such conditions.
No patient had more than three comorbid conditions.
There was a significant correlation between the year of first
dialysis and the mean age at the start of dialysis (Y = 1.412x —
70.85, r = 0.962, P < 0.001, Fig. 1). The annual acceptance rate
(AR) increased dramatically from 4.3 (1971) to 193.5 patients
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Year of first dialysis
Fig. 1. Annual changes in the acceptance rate (0. AR), age at entry
(a), and prevalence rate (•, PR) for dialysis patients in Okinawa from
1971—1990. AR and PR were expressed as the number of patients per
million population. The increase in AR, age at entry (year) and PR were
all significantly correlated with the year of starting dialysis.
Table 3. Results of proportional hazard analysis of the survival of
chronic dialysis patients in Okinawa (1971—1990)
Covariates Hazard ratio 95% CI
Sex female (N = 824)
male (N = 1,158)
1.00
1.09 0,93—1.28
Primary renal Nondiabetic (N = 1,608) 1.00
disease Diabetic (N = 374) 1.88 1.55—2.28
Age at start of 0—34 (N = 512) 1.00
hemodialysis 35—44 (N = 353)
45—54 (N = 359)
55—64 (N = 357)
65 + (N = 401)
1.66
2.74
4.54
7.51
1.55—1.76
2.41—3.11
3.74—5.50
5.81—9.70
Year at start of '71—'75 (N = 98) 1.00
hemodialysis '76—'80 (N = 330)
'81—'85 (N = 601)
'86—'90 (N = 953)
0.65
0.43
0.28
0.59—0.72
0.35—0.52
0.20—0.38
CI denotes confidence interval.
per million population (1990). There was a significant cor-
relation between the year of first dialysis and the AR (Y =
9.264x — 660, r 0.985, P < 0.001, Fig. 1). Both diabetic and
nondiabetic patients increased during the study period. The
annual gross mortality rate (GMR) fell initially, but has re-
mained stable since 1977. Therefore, the prevalence of dialysis
increased linearly with the year of first dialysis (Y 86.29x —
6561, r 0.995, P < 0.001, Fig. 1).
Results
The overall cumulative probability of survival was 0.884 (1
year), 0.683 (5 years), 0.545 (10 years), and 0.438 (15 years),
respectively. The hazard for death was 0.006 (60 months),
0.0084 (120 months), and 0.0026 (180 months) with the peak
hazards being at 0.0148 (6 months) and 0.0126 (108 months).
The gross mortality rate was stable despite the large increase in
AR (Table 1).
Table 3 shows the results of Cox proportional hazard analysis
of the survival of chronic dialysis patients in Okinawa. There
was no marked sex difference in survival. The hazard ratio (HR)
Survival time, months
Fig. 2. The probability of survival for patients with primary renal
disease. Estimates were obtained by the Kaplan-Meier method. Dia-
betic patients had a significantly worse prognosis than nondiabetic
patients.
Survival time, months
Fig. 3. The probability of survival for 1,983 patients according to age
group at the start of dialysis. Estimates were obtained by the Kaplan-
Meier method. The relationship between age and survival hazard was
log-linear.
for males was 1.09, with a 95% confidence interval (CI) of 0.93
to 1.28 when the HR for females was taken as 1.00. The mean
age at the start of dialysis was 51.0 for females and 46.9 for
males.
Diabetic patients had a significantly worse prognosis when
compared to nondiabetic patients (HR: 1.88; 95% CI: 1.55 to
2.28). The probability of survival at five years was 0.731 for
nondiabetic patients and only 0.418 for diabetic patients. Figure
2 shows the probability of survival for both diabetic and
nondiabetic patients. The mean age at the start of dialysis was
46.3 years for nondiabetic and 59.3 years for diabetic patients.
Age at the start of dialysis had, as expected, a significant
effect on patient survival. When the HR for age <35 was taken
as 1.00, the calculated HR was 1.66 for patients aged 35 to 44
years, 2.74 for those aged 45 to 54 years, 4.54 for those aged 55
to 64 years, and 7.51 for those 65 years old, respectively
(Table 3). Figure 3 shows the probability of survival for each
age category.
Table 4 shows a comparison of the death rate between
dialysis patients and the general population in Okinawa. The
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Table 4. Comparison of the probability of death on dialysis (12
months) and the crude annual death of the general population
(ratio = HD/GP)
Dialysis patients: General population:
probability of crude death rate
Age at entry death after 12 from 1985 census
year months (HD) (GP) Ratio
0—34 0.0812 0.00067 121.2
35—44 0.0525 0.00129 40.7
45—54 0.0710 0.00302 23.5
55—64 0.1141 0.00662 17.2
65+ 0.2633 0.03532 7.5
Total 0.1166 0.0045 25.9
C)
>
0t0000
1.0
0.8
0.6
0.4
0.2
Survival time, months
240
Fig. 4. The probability of survival based on the year of starting dialysis(5-year periods). Estimates were obtained by the Kaplan-Meier
method. The hazard ratio decreased from 1971—1975 (1.00) to 1986—1990
(0.28).
annual death rate was 4.5 to 5.6 (average: 4.95) per thousand
population over the last two decades in Okinawa. The crude
death rate for each age category was calculated from the 1985
census data. The relative risk of death was very high in young
patients, but it decreased with age.
Figure 4 shows the cumulative probability of survival for
those starting dialysis in each five-year period. The HR de-
creased from 1.00 (1971 to 1975) to 0.65 (1976 to 1980), 0.43
(1981 to 1985), and 0.28 (1986 to 1990), respectively (Table 2).
The mean age (SD) at the start of dialysis was 34.2 (10.8) years
in 1971 to 1975, 40.3 (15.0) years in 1976 to 1980, 47.9 (16.5)
years in 1981 to 1985, and 53.3 (16.7) years in 1986 to 1990.
Cox models were next run without the patients who had
started dialysis by the end of 1975. The HR (95% CI) for males
was 1.12 (0.95 to 1.33). The HR (95% CI) for diabetic patients
was 1.88(1.55 to 2.28). The HR (95% CI) was 0.79 (0.70 to 0.90)
for 1981 to 1985 and 0.63 (0.49 to 0.81) for 1986 to 1990 when the
HR in 1976 to 1980 was taken as 1.00.
Table 5 shows the causes of death for patients starting
dialysis in each five-year period. Cardiac deaths decreased, but
deaths due to withdrawal increased. Deaths due to infection,
sudden death, and vascular causes remained almost constant.
Discussion
A large fraction of ESRD patients often leave the registry
because of renal transplantation or transfer to other locations, a
problem that frequently complicates data collection and analy-
Table 5. Causes of death in relation to year of starting dialysis
Causes of Year of starting dialysis %
death 1971—1975 1976—1980 1981—1985 1986—1990 All
Infection 9.2 11.6 22.8 12.3 15.8
Withdrawal 6.2 11.6 16.8 30.1 18.0
Cardiac 64.6 36.3 28.5 22.7 32.7
Sudden 3.1 5.5 6.0 9.2 6.4
Vascular 9.2 15.8 12.1 11.0 12.4
Other 7.7 19.2 13.8 14.7 14.7
Deceased N = 65 N = 146 N = 232 N = 162 N = 605
sis in the case of both national [1, 2, 15] and local registries
[5—7]. However, as shown in Table 1, the number of patients
undergoing renal transplantation or transfer was very small and
their outcomes were all known in the Okinawa registry. More-
over, the population of Okinawa did not change much over the
study period, so we could evaluate various features of the care
of ESRD patients. The Cox model is a statistically valid one to
use for this purpose [16, 17].
There is no clear explanation for the linear increase in AR.
Both diabetic and nondiabetic patients showed an increase.
This was either due to an increase in referral and possible
luxury introduction to dialysis and/or due to a true increase in
the incidence of ESRD. The rate of increase in the age of the
new patients and the increase in the incidence of diabetes were
much steeper than for dialysis patients in USA [18]. Control of
blood pressure may decrease cardiovascular death and delay
the onset of renal failure, but it may eventually increase the
incidence of ESRD [13]. However, hypertensive nephrosclero-
sis accounts for less than 5% of Japanese dialysis patients [15,
19], while it ranges from 7% [17] to more than 50% in the USA
[19].
The AR did not correlate with the survival rate (Table 1), a
quite different finding from that of Kjellstrand, Hylander, and
Collins [20]. Moreover, they showed an inverse relationship
between the transplantation rate and cumulative four-year
survival. The transplantation rate was less than 20 per million
per four years in our registry. This low rate of transplantation
may have influenced the patient survival data, since young and
healthy patients remained on dialysis who would otherwise
have been transplanted [20]. However, this factor did not affect
our overall results, since the number of transplants was small
and the transplantation rate did not change over the last two
decades (Table I).
There was no survival difference between females and males
as was previously reported [17]. Some studies have indicated
that female patients have a better survival than males [6, 20,
21], but the small differences could reflect the difference in
mortality in the general population. The life expectancy in
Okinawa (1990) is 83.70 years for females and 76.34 years for
males [9]. Interestingly, the age at initiation of dialysis was
about four years older in females (mean: 51.0 years) than males
(mean: 46.9 years).
Diabetic patients did worse than nondiabetic patients as has
been reported before [6, 22, 23]. Whether this is related to
predialysis complications or related to dialysis therapy itself
remains uncertain. The hazard ratio (relative risk) in our
registry was 1.88. This value was smaller than the value of 2.9
reported by Woffe et al [6] and that of 2.61 reported by Held et
al [21, 23]. Differences in the reference groups and in the
0 60 120 180
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classification of renal disease may have led to these different
results.
The age at the start of dialysis is a significant risk factor for
the survival of dialysis patients [16, 17]. The relationship
between this age and the survival hazard has been reported to
be log-linear [17], although Umen and Le [16] reported a
nonlog-linear relationship. We estimated that the relative risk of
death was 25 times higher for the dialysis patients than for the
background general population (Table 4). In the Diaphane
collaborative study, the risk was estimated 12 times higher for
dialysis patients [251. The mortality is higher in males and
increases with age. However, the relative risk was rather low in
our elderly dialysis patients (Table 4),
For the first five-year period (1971 to 1975), the prognosis was
worse than in the other three five-year periods. Judging from
our current standards, patients in the first five-year period were
underdialyzed. Therefore, the mortality rate was higher even
though they were nondiabetic and young. The probability of
survival improved slightly from the second to the fourth five-
year periods (Fig. 4). Thus, the mortality of the dialysis patients
in Okinawa appeared to be stable or even improved slightly
despite the large increases in AR, diabetic patients, and older
new patients. Matson and Kjellstrand [26] reported an improve-
ment of the survival rate in diabetic patients. Hakim has stated
that optimal dialysis will prevent or reduce the incidence of
cardiovascular events [271, which are the main cause of death in
patients on dialysis [15]. Consequently, the decrease in cardiac
deaths in our dialysis population (Table 5) may have contrib-
uted to the improvement in survival.
In summary, the mortality rate of chronic dialysis patients in
Okinawa has been stable or has improved slightly, despite a
large increase in the AR, older new patients, and diabetic
patients. Improvements in dialysis techniques and patient care
may have overcome the adverse effect of these risk factors. In
this regard, one may argue that Japanese economic success may
be a factor in the rapid improvement in life expectancy [28] and
also in the stable mortality of dialysis patients. However, a
prospective study is needed to precisely evaluate the effects of
dialysis regimen [211, nutrition [22, 25], and complicating ill-
nesses [5, 251 on the survival of chronic dialysis patients. More
efforts to improve survival are needed, since the relative risk of
dying is still very high for patients on dialysis. Death is the
severest consequence of inadequate dialysis and can be used as
an index of adequacy of dialysis therapy [291.
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